MX170925B - PROCEDIMIENTO PARA PRODUCIR EL COMPLEJO A10255 O EL FACTOR B,C,E,F,G o H o CUALQUIER COMBINACION DEL LOS MISMOS - Google Patents

PROCEDIMIENTO PARA PRODUCIR EL COMPLEJO A10255 O EL FACTOR B,C,E,F,G o H o CUALQUIER COMBINACION DEL LOS MISMOS

Info

Publication number
MX170925B
MX170925B MX009771A MX977187A MX170925B MX 170925 B MX170925 B MX 170925B MX 009771 A MX009771 A MX 009771A MX 977187 A MX977187 A MX 977187A MX 170925 B MX170925 B MX 170925B
Authority
MX
Mexico
Prior art keywords
complex
nrrl
factor
combination
procedure
Prior art date
Application number
MX009771A
Other languages
English (en)
Spanish (es)
Inventor
Harbert Anderw Rirst
Eugene Thomas Seno
Karl Heinz Michel
Laverne Dwaine Boeck
Maruin Marthin Hoehn
Otis Webster Godfrey Jr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX170925B publication Critical patent/MX170925B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MX009771A 1986-12-15 1987-12-15 PROCEDIMIENTO PARA PRODUCIR EL COMPLEJO A10255 O EL FACTOR B,C,E,F,G o H o CUALQUIER COMBINACION DEL LOS MISMOS MX170925B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94189486A 1986-12-15 1986-12-15
US94147386A 1986-12-15 1986-12-15

Publications (1)

Publication Number Publication Date
MX170925B true MX170925B (es) 1993-09-22

Family

ID=27130157

Family Applications (1)

Application Number Title Priority Date Filing Date
MX009771A MX170925B (es) 1986-12-15 1987-12-15 PROCEDIMIENTO PARA PRODUCIR EL COMPLEJO A10255 O EL FACTOR B,C,E,F,G o H o CUALQUIER COMBINACION DEL LOS MISMOS

Country Status (15)

Country Link
EP (1) EP0274873B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS63258585A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR880007553A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1023758C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU604806B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3781878T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK654987A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2052584T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3006408T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU199559B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE60394B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL84819A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX170925B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ222895A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT86364B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229362A (en) * 1986-12-15 1993-07-20 Eli Lilly And Company Antibiotic A10255 complex and factors, and process and production therefor
ZA879415B (en) * 1986-12-15 1989-08-30 Lilly Co Eli Antibiotic a10255 complex and factors,microorganisms,process and production therefor
ES2056954T3 (es) * 1987-06-19 1994-10-16 Sandoz Ag Peptolidos ciclicos.
IT1234197B (it) * 1988-06-14 1992-05-06 Mini Ricerca Scient Tecnolog Antibiotici ottenuti mediante coltivazione aerobica controllata dello streptomyces s.p. ncib 12629
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
PT1353696E (pt) 2001-01-26 2007-02-28 Schering Corp Combinações de activador (es) do receptor activado por proliferador do peroxisoma (ppar) e inibidor (es) da absorção de esterol e tratamentos para indicações vasculares
SK287746B6 (sk) 2001-01-26 2011-08-04 Schering Corporation Použitie substituovaných azetidinónových zlúčenín na liečenie sitosterolémie
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
ATE345793T1 (de) 2001-09-21 2006-12-15 Schering Corp Behandlung von xanthom mittels azetidinon- derivate als hemmer der sterol absorption
WO2004043457A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
US20060243825A1 (en) 2003-02-18 2006-11-02 Keith Laidler Dispenser pump
MXPA05009501A (es) 2003-03-07 2005-10-18 Schering Corp Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
ATE406364T1 (de) 2003-03-07 2008-09-15 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
MXPA05009502A (es) 2003-03-07 2005-10-18 Schering Corp Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
NZ599175A (en) * 2009-09-02 2013-05-31 Piramal Entpr Ltd Antibiotic compounds

Also Published As

Publication number Publication date
GR3006408T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-06-21
DE3781878D1 (de) 1992-10-29
AU8249387A (en) 1988-07-28
EP0274873A3 (en) 1989-08-09
NZ222895A (en) 1992-08-26
KR880007553A (ko) 1988-08-27
PT86364A (en) 1988-01-01
IL84819A (en) 1993-07-08
CN87108341A (zh) 1988-08-10
IE60394B1 (en) 1994-07-13
JPS63258585A (ja) 1988-10-26
AU604806B2 (en) 1991-01-03
IE873390L (en) 1988-06-15
ES2052584T3 (es) 1994-07-16
EP0274873B1 (en) 1992-09-23
HUT49376A (en) 1989-09-28
PT86364B (pt) 1990-11-07
DK654987A (da) 1988-09-23
DK654987D0 (da) 1987-12-14
CN1023758C (zh) 1994-02-16
DE3781878T2 (de) 1993-03-11
HU199559B (en) 1990-02-28
EP0274873A2 (en) 1988-07-20

Similar Documents

Publication Publication Date Title
MX170925B (es) PROCEDIMIENTO PARA PRODUCIR EL COMPLEJO A10255 O EL FACTOR B,C,E,F,G o H o CUALQUIER COMBINACION DEL LOS MISMOS
ES534078A0 (es) Un procedimiento para preparar un complejo de compuestos antibioticos que contienen azufre
MX168708B (es) Procedimiento para la produccion de antibioticos
UA13320A (uk) Спосіб одержаhhя комплексhого аhтибіотика циклоспоріhу та/або його компоhеhтів та штам грибка tolypocladium varium
ES485074A1 (es) Un metodo de produccion de la mezcla antibiotica a-21978
KR840005487A (ko) 이노신 및 /또는 구아노신의 제조방법
ES8504250A1 (es) Un procedimiento para la preparacion del antibiotico a47934
ES8607395A1 (es) Un procedimiento para la produccion de nuevos antibioticos de eter policiclico
ES8505723A1 (es) Un procedimiento para fabricar un complejo aad 216 antibiotico
TW234147B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK340882A (da) Fremgangsmaade til fremstilling af sur protease og mutanter af slaegten rhizopus, som danner denne
ES475853A1 (es) Un procedimiento para la preparacion de los factores a, b, c, y d del antibiotico a-40104
MX167931B (es) Procedimiento para la produccion de 19-epi-dianemicina
ES8504935A1 (es) Un metodo de produccion de un antibiotico
ES8102592A1 (es) Procedimiento de preparar antibioticos sisomicinicos.
DE3884741D1 (de) Mikrobiologisches Verfahren zur Herstellung von UK-61.689 und Mikroorganismen zur Verwendung darin.
DE69302267D1 (de) Actinoplanes als erzeuger von rapamycin
GB1202007A (en) Production of phenylalanine by fermentation
GB1453905A (en) Fermentation process for producing optically active l-lysine
GB1430558A (en) Process for producing inosine-5,-monophosphate
ES8405439A1 (es) Procedimiento para producir acido clavulanico.
GB1433470A (en) Process for producing guanosine-5,-monophosphate
ES8506043A1 (es) Un procedimiento para la preparacion de una macrolida.
GB1148727A (en) A method for the production of inosine
GB1188684A (en) Method For Producing L-Glutamic Acid